William D. Turner Sierra Oncology, Inc. (SRRA) insider trading activity

SRRA Quotes by TradingView

William D. Turner is Chief Reg & Tech Ops Officer of Sierra Oncology, Inc.. Currently has a direct ownership of 0 shares of SRRA, which is worth approximately $0. The most recent transaction as insider was on Apr 06, 2022, when has been sold 6,347 shares (Common Stock) at a price of $37.25 per share, resulting in proceeds of $236,426. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

William D. Turner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 06 2022
SELL
Open market or private sale
$236,426 $37.25 p/Share
6,347 Reduced 100.0%
0 Common Stock
Apr 06 2022
BUY
Exercise of conversion of derivative security
$76,481 $12.05 p/Share
6,347 Added 50.0%
6,347 Common Stock
Apr 05 2022
SELL
Open market or private sale
$3,709 $37.09 p/Share
100 Reduced 100.0%
0 Common Stock
Apr 05 2022
BUY
Exercise of conversion of derivative security
$1,205 $12.05 p/Share
100 Added 50.0%
100 Common Stock
Mar 18 2022
SELL
Open market or private sale
$3,705 $37.05 p/Share
100 Reduced 100.0%
0 Common Stock
Mar 18 2022
BUY
Exercise of conversion of derivative security
$1,205 $12.05 p/Share
100 Added 50.0%
100 Common Stock
Mar 17 2022
SELL
Open market or private sale
$127,968 $37.06 p/Share
3,453 Reduced 100.0%
0 Common Stock
Mar 17 2022
BUY
Exercise of conversion of derivative security
$41,609 $12.05 p/Share
3,453 Added 50.0%
3,453 Common Stock
Feb 07 2022
SELL
Open market or private sale
$323,200 $32.32 p/Share
10,000 Reduced 100.0%
0 Common Stock
Feb 07 2022
BUY
Exercise of conversion of derivative security
$120,500 $12.05 p/Share
10,000 Added 50.0%
10,000 Common Stock
Jan 26 2022
SELL
Open market or private sale
$135,250 $27.05 p/Share
5,000 Reduced 100.0%
0 Common Stock
Jan 26 2022
BUY
Exercise of conversion of derivative security
$60,250 $12.05 p/Share
5,000 Added 50.0%
5,000 Common Stock

Also insider at

VERA
Vera Therapeutics, Inc. Healthcare
Chief Development Officer
WDT

William D. Turner

Chief Reg & Tech Ops Officer
San Mateo, CA

Track Institutional and Insider Activities on SRRA

Follow Sierra Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRRA shares.

Notify only if

Insider Trading

Get notified when an Sierra Oncology, Inc. insider buys or sells SRRA shares.

Notify only if

News

Receive news related to Sierra Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SRRA